Posted on Leave a comment

Antibacterial Drugs Market: Global Market Size, Industry Share, Approaches and Forecast 2017-2025, Acute Market Reports

“Acute Market Reports Logo”

The antibacterial drugs market was valued at USD 43,203.5 Mn in 2017 and is expected to reach USD 47,088.9 Mn by 2025, expanding at a CAGR of 1.15% from 2017 to 2025.

Antibacterial Drugs Market – Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2017 – 2025, the antibacterial drugs market was valued at USD 43,203.5 Mn in 2017, and is expected to reach USD 47,088.9 Mn by 2025, expanding at a CAGR of 1.15% from 2017 to 2025.

Market Insights

Antibacterial drugs are derived from bacteria or molds or are synthesized de novo. These drugs treat infectious diseases caused by gram positive, gram negative, aerobic and anaerobic bacteria that cannot be treated by any other method unlike other diseases. Antibacterial drugs have several mechanisms of action, including inhibiting cell wall synthesis, increasing cell membrane permeability, interfering with protein synthesis, nucleic acid metabolism, and other metabolic processes.

Browse Full Report: http://www.acutemarketreports.com/report/antibacterial-drugs-by-class-market

The alarming antibacterial-resistance crisis has penetrated the awareness of clinicians, researchers, policymakers, governments and the public at large. The key factors assisting the growth of antibacterial drugs market are mounting prevalence of infectious diseases, government support, and increased research and development activities. However, evolving drug-resistant species, launch of generics, and upcoming patent expirations are anticipated to restrict the growth of the global market through 2022. Globally, the rise in geriatric population is also being considered as one of the key growth factors as it will indirectly increase the demand for various antibacterial drugs. The demand for antibacterial drugs will continue to rise mainly due to increased prevalence of resistant species that demand development of innovative molecules.

Pipeline Analysis

The phase III drugs included in the pipeline analysis are solithromycin (Cempra, Inc.), VivaGel/ SPL7013 (Starpharma Holdings Limited), surotomycin (Merck & Co.), MK-3415A (Merck & Co.) and others. According to market experts, these upcoming drugs assure to provide enhanced efficacy, shorter onset of action and fewer side effects as compared to the currently available antibacterial drugs. Thus, future commercialization of these drugs during the forecast period 2016 – 2022 is anticipated to have a reflective impact on the growth of the overall antibacterial drugs market.

Key Market Movements:

• Asia Pacific presently dominates the overall market and is also projected to experience the fastest growth throughout the forecast period
• The rising incidence and prevalence of antibacterial drug resistance bacteria strains such as Methicillin-resistant Staphylococcus aureus (MRSA)
• Stringent regulatory policies applied by FDA and other government agencies across the world is expected to reduce the risk of infection outbreak in hospitals
• Novel and developed treatments in pipeline are expected to assist the overall market growth of antibacterial drugs market

ToC:

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology

Chapter 2 Executive Summary
2.1 Global Antibacterial Drugs Market Portaiture
2.2 Global Antibacterial Drugs Treament Market, by Drug Class, 2015 (USD Mn)
2.3 Relativity Analysis: Global Antibacterial Drugs Market, by Geography, 2015 & 2022 (USD Mn)

Chapter 3 Antibacterial Drugs Market: Market Dynamics and Outlook
3.1 Antibacterial Drugs Market Overview
3.2 Market Inclination Insights 
3.3 Market Dynamics
3.3.1 Drivers
3.3.2 Challenges
3.3.3 Opportunities
3.4 Attractive Investment Proposition
3.5 Competitive Analysis
3.5.1 Market Share Analysis: Global Antibacterial Drugs Market, 2015 (Value %)…….

Browse Full Report: http://www.acutemarketreports.com/report/antibacterial-drugs-by-class-market

About Us:
Acute Market Reports is the sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

Company: http://www.acutemarketreports.com/

Media Contact
Company Name: Acute Market Reports
Contact Person: Chris Paul
Email: sales@acutemarketreports.com
Phone: Toll Free US/Canada: +1-855-455-8662
Address:105 N 1st ST #429, SAN JOSE, CA 95103
City: SANJOSE
State: CALIFORNIA
Country: United States
Website: http://www.acutemarketreports.com/report/antibacterial-drugs-by-class-market